Prevymis 480 mg/24 ml, Konzentrat zur Herstellung einer Infusionslösung

7680666530023 CH-66653 Konzentrat
Prevymis 480 mg/24 ml, Konzentrat zur Herstellung einer Infusionslösung
Prevymis 480 mg/24 ml, Konzentrat zur Herstellung einer Infusionslösung
Prevymis 480 mg/24 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
480.0 MG Substance Wirkstoff (Principe actif)
(N/A)
3600.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
45.8 MG Substance HBESI

Reimbursement information

Public price
CHF 392.25
Specialties list
Yes
Generic
No
SL addition date: 01/11/2020

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
66653
Drug name
Prevymis, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
LSMP
ATC Code
J05AX18
Authorization status
Z
Dispensing category
A
First authorization
05/04/2018
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
Cytomegalovirus-(CMV)-Prophylaxe

Package details

Description (FR)
PREVYMIS 480 mg/24 ml sol inj 480 mg 1 pce
Description (DE)
PREVYMIS 480 mg/24 ml Inj Lös 480 mg 1 Stk
Market launch
05/04/2018
Narcotic (BTM)
No

Other package sizes (1)

PREVYMIS 240 mg/12 ml sol inj 240 mg 1 pce
1 DUR
GTIN: 7680666530016
View